1. Home
  2. NAMS vs LXP Comparison

NAMS vs LXP Comparison

Compare NAMS & LXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • LXP
  • Stock Information
  • Founded
  • NAMS 2019
  • LXP 1993
  • Country
  • NAMS Netherlands
  • LXP United States
  • Employees
  • NAMS N/A
  • LXP N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • LXP Real Estate Investment Trusts
  • Sector
  • NAMS Health Care
  • LXP Real Estate
  • Exchange
  • NAMS Nasdaq
  • LXP Nasdaq
  • Market Cap
  • NAMS 3.1B
  • LXP 2.5B
  • IPO Year
  • NAMS N/A
  • LXP 1993
  • Fundamental
  • Price
  • NAMS $32.86
  • LXP $9.23
  • Analyst Decision
  • NAMS Strong Buy
  • LXP Hold
  • Analyst Count
  • NAMS 9
  • LXP 3
  • Target Price
  • NAMS $41.89
  • LXP $10.50
  • AVG Volume (30 Days)
  • NAMS 974.1K
  • LXP 3.8M
  • Earning Date
  • NAMS 11-05-2025
  • LXP 10-30-2025
  • Dividend Yield
  • NAMS N/A
  • LXP 5.86%
  • EPS Growth
  • NAMS N/A
  • LXP 203.57
  • EPS
  • NAMS N/A
  • LXP 0.27
  • Revenue
  • NAMS $64,006,000.00
  • LXP $363,003,000.00
  • Revenue This Year
  • NAMS N/A
  • LXP N/A
  • Revenue Next Year
  • NAMS $1.67
  • LXP $5.19
  • P/E Ratio
  • NAMS N/A
  • LXP $34.11
  • Revenue Growth
  • NAMS 762.15
  • LXP 6.63
  • 52 Week Low
  • NAMS $14.06
  • LXP $6.85
  • 52 Week High
  • NAMS $34.62
  • LXP $9.95
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 72.18
  • LXP 54.52
  • Support Level
  • NAMS $27.15
  • LXP $8.88
  • Resistance Level
  • NAMS $34.59
  • LXP $9.55
  • Average True Range (ATR)
  • NAMS 1.47
  • LXP 0.17
  • MACD
  • NAMS 0.50
  • LXP -0.02
  • Stochastic Oscillator
  • NAMS 73.37
  • LXP 51.13

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About LXP LXP Industrial Trust (Maryland REIT)

LXP Industrial Trust is a real estate investment trust principally involved in the ownership of equity and debt investments in single-tenant properties and land throughout the United States. The majority of the revenue is earned through rental revenue.

Share on Social Networks: